Emerging Clinical Efficacy and Safety Data in Recurrent and Metastatic Cervical Cancer

Emerging Clinical Efficacy and Safety Data in Recurrent and Metastatic Cervical Cancer is organized by Prime Education, LLC.

Release Date: May 12, 2023
Expiration Date: May 13, 2024

Agenda:
• Clinical Efficacy and Safety Data for Novel and Emerging Therapies for Recurrent or Metastatic Cervical Cancer
• Integrating Expert Guidelines and Patient-Specific Factors Into Treatment Decision-Making

LEARNING OBJECTIVES
• Assess recent clinical efficacy and safety data on new and emerging therapies for recurrent and metastatic cervical cancer
• Apply current expert guidelines and recent clinical trial data to treatment decision-making for patients with advanced cervical cancer.

0.5 CME/CE | 0.5 CPE | 0.5 CNE | 0.5 AMA PRA Category 1 Credit™ | 0.5 Contact Hours | 0.5 IPCE | 0.1 CEUs